Frontiers in Pharmacology2025EN
StarTRAC-CYP2D6: a method for CYP2D6 allele-specific copy number determination using digital PCR
Zusammenfassung
Front Pharmacol. 2025 Dec 2;16:1715830. doi: 10.3389/fphar.2025.1715830 StarTRAC-CYP2D6: a method for CYP2D6 allele-specific copy number determination using digital PCR Wendy Y Wang Wendy Y Wang 1 Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Children’s Mercy Research Institute (CMRI), Kansas City, MO, United States Conceptualization, Data curation, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft, Writing – revie
Kerninformationen
Copyright © 2025 Wang, Boone, Lin, Joun and Gaedigk. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are cred...
DNA quantity and possible interfering variants should be considered when optimizing workflows and accurately interpreting results. Protocols are currently being developed for higher-plex CN testing and discrimination.Keywords: CYP2D6, copy number variation, allele-specific PCR, digital PCR, genotypi...
With the frequency of SVs in the United States being estimated at 3.5%–8.4% (depending on ancestry), it is imperative for any CYP2D6 genotyping platform or implementation program to accurately capture SVs (Black et al., 2012; Del Tredici et al., 2018; Patel et al., 2024). Current stand-alone CNV met...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
BMJ Open2025
Effects and safety of dapagliflozin in paediatric hereditary kidney disease: protocol for a multicentric, prospective, open and randomised crossover study (DAPA-PedHKD)
Breathe2025
Advancing COPD management through novel pharmacological agents: ensifentrine and dupilumab
Computational and Structural Biotechnology Journal2025
Advancing rare disease therapeutics through digital twins: Opportunities in drug development and precision dosing
CPT: Pharmacometrics & Systems Pharmacology2025
Exposure–Response Analysis of Repotrectinib to Support the Dose Recommendation for Patients With ROS1-Positive NSCLC or NTRK-Positive Solid Tumors
International Journal of Tuberculosis and Lung Disease2025